The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of BBI608, a cancer stemness inhibitor, administered with paclitaxel (PTX) as combination therapy (Rx) for pretreated unresectable or recurrent gastric cancer.
 
Kohei Shitara
Honoraria - Chugai Pharma; Takeda
Consulting or Advisory Role - Bayer; Chugai Pharma; Lilly
Research Funding - Bayer; Chugai Pharma; Daiichi Sankyo; Sanofi; Sumitomo Group; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Yasutoshi Kuboki
No Relationships to Disclose
 
Yoshiaki Nakamura
No Relationships to Disclose
 
Ayako Doi
No Relationships to Disclose
 
Kazuaki Harada
No Relationships to Disclose
 
Akihito Kawazoe
No Relationships to Disclose
 
Toshihiko Doi
Honoraria - Chugai Pharma; Novartis
Consulting or Advisory Role - Amgen; Lilly; Merck Serono; Otsuka
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Janssen (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); NanoCarrier (Inst); Nippon Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst); Quintiles (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Zenyaku Kogyo (Inst)
 
Takayuki Yoshino
Honoraria - Chugai Pharma; Takeda
Research Funding - Daiichi Sankyo; Lilly; Pfizer; Sumitomo Group; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Yasuhide Yodo
Employment - Sumitomo Group
 
Reigetsu Yoshikawa
Employment - Sumitomo Group
 
Atsushi Ohtsu
Employment - Celgene (I)
Honoraria - Chugai Pharma; Daiichi Sankyo; Eisai; Merck Serono; Taiho Pharmaceutical